Swiss pharmaceutical giant Novartis says it is watching "very carefully" how the reciprocal tariff policy proposed by the ...

Swiss private bank Julius Baer delivered a total pay package to its ad interim chief executive officer Nic Dreckmann of 5.8 ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Ofatumumab, a fully human anti-CD20 monoclonal antibody, is a disease-modifying therapy (DMT) approved for the treatment of ...

Carol Braddick, a coach who researches the industry, says chatbots are typically offered to middle managers, team leaders and individuals. Delta, Experian, Kraft Heinz, WPP and Novartis are among the ...

Charlottenburg, Soundfabrik Berlin, a premier recording studio, has long been a hub for musicians, producers, and audio ...

Gilead's HIV portfolio remains dominant but faces Medicare Part D pricing pressure, limiting future growth potential. New ...

American stocks crushed European stocks in the last decade, but that trend has reversed course in 2025 due to uncertainty ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...